Researchers have found that semaglutide therapy is effective at sustaining weight loss in patients without diabetes who are overweight or have obesity.
Researchers have found that semaglutide therapy is effective at sustaining weight loss in patients without diabetes who are overweight or have obesity.
1. In this randomized controlled trial, semaglutide was more effective in reducing heart failure-related symptoms and physical limitations in patients with obesity-related heart failure and type 2 diabetes mellitus (T2DM) than placebo. 2. Patients with obesity-related heart failure and T2DM exhibited greater weight loss with semaglutide than placebo. Evidence Rating Level: 1 (Excellent) Study Rundown: Heart
Pharmacology Consult: GLP-1 receptor agonists for weight loss management healio.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from healio.com Daily Mail and Mail on Sunday newspapers.